Jane Street’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10M | Buy |
125,300
+57,800
| +86% | +$4.77M | ﹤0.01% | 2531 |
|
|
2025
Q4 | $5.75M | Sell |
67,500
-15,200
| -18% | -$1.25M | ﹤0.01% | 3021 |
|
|
2025
Q3 | $6.43M | Buy |
82,700
+34,800
| +73% | +$2.72M | ﹤0.01% | 3040 |
|
|
2025
Q2 | $3.75M | Buy |
47,900
+24,600
| +106% | +$1.83M | ﹤0.01% | 3411 |
|
|
2025
Q1 | $1.69M | Sell |
23,300
-72,800
| -76% | -$5.21M | ﹤0.01% | 4632 |
|
|
2024
Q4 | $7.11M | Sell |
96,100
-840,500
| -90% | -$58.8M | ﹤0.01% | 2237 |
|
|
2024
Q3 | $61.8M | Buy |
936,600
+693,900
| +286% | +$50.4M | 0.01% | 586 |
|
|
2024
Q2 | $22.4M | Buy |
242,700
+148,600
| +158% | +$13.2M | 0.01% | 1226 |
|
|
2024
Q1 | $8.99M | Sell |
94,100
-175,700
| -65% | -$14.8M | ﹤0.01% | 1929 |
|
|
2023
Q4 | $20.6M | Buy |
269,800
+104,200
| +63% | +$7.25M | 0.01% | 1238 |
|
|
2023
Q3 | $11.5M | Buy |
165,600
+158,300
| +2,168% | +$12.7M | ﹤0.01% | 1636 |
|
|
2023
Q2 | $689K | Sell |
7,300
-22,300
| -75% | -$1.94M | ﹤0.01% | 5813 |
|
|
2023
Q1 | $2.45M | Sell |
29,600
-49,300
| -62% | -$3.88M | ﹤0.01% | 3473 |
|
|
2022
Q4 | $5.89M | Sell |
78,900
-200
| -0.3% | -$15.4K | ﹤0.01% | 2266 |
|
|
2022
Q3 | $6.54M | Sell |
79,100
-2,900
| -4% | -$279K | ﹤0.01% | 2210 |
|
|
2022
Q2 | $7.8M | Sell |
82,000
-104,600
| -56% | -$10.8M | ﹤0.01% | 2043 |
|
|
2022
Q1 | $22M | Buy |
186,600
+63,300
| +51% | +$7.1M | 0.01% | 1191 |
|
|
2021
Q4 | $16M | Buy |
123,300
+23,300
| +23% | +$2.72M | 0.01% | 1379 |
|
|
2021
Q3 | $11.3M | Buy |
100,000
+11,600
| +13% | +$1.32M | ﹤0.01% | 1654 |
|
|
2021
Q2 | $9.16M | Buy |
88,400
+28,200
| +47% | +$2.66M | ﹤0.01% | 1831 |
|
|
2021
Q1 | $5.04M | Buy |
60,200
+17,800
| +42% | +$1.5M | ﹤0.01% | 2396 |
|
|
2020
Q4 | $3.87M | Sell |
42,400
-43,400
| -51% | -$3.6M | ﹤0.01% | 2460 |
|
|
2020
Q3 | $6.85M | Buy |
85,800
+40,500
| +89% | +$3.16M | ﹤0.01% | 1541 |
|
|
2020
Q2 | $3.13M | Buy |
45,300
+13,800
| +44% | +$981K | ﹤0.01% | 2445 |
|
|
2020
Q1 | $1.98M | Sell |
31,500
-28,200
| -47% | -$2.03M | ﹤0.01% | 2027 |
|
|
2019
Q4 | $4.64M | Buy |
59,700
+18,900
| +46% | +$1.48M | 0.01% | 1157 |
|
|
2019
Q3 | $2.99M | Buy |
40,800
+22,800
| +127% | +$1.6M | ﹤0.01% | 1410 |
|
|
2019
Q2 | $1.11M | Sell |
18,000
-13,200
| -42% | -$798K | ﹤0.01% | 2565 |
|
|
2019
Q1 | $1.99M | Sell |
31,200
-17,100
| -35% | -$976K | ﹤0.01% | 2031 |
|
|
2018
Q4 | $2.47M | Buy |
48,300
+24,600
| +104% | +$1.24M | 0.01% | 1513 |
|
|
2018
Q3 | $1.38M | Sell |
23,700
-4,200
| -15% | -$205K | ﹤0.01% | 2363 |
|
|
2018
Q2 | $1.35M | Buy |
27,900
+16,500
| +145% | +$770K | ﹤0.01% | 2381 |
|
|
2018
Q1 | $530K | Sell |
11,400
-3,300
| -22% | -$143K | ﹤0.01% | 3421 |
|
|
2017
Q4 | $552K | Sell |
14,700
-5,100
| -26% | -$187K | ﹤0.01% | 3050 |
|
|
2017
Q3 | $721K | Buy |
19,800
+12,300
| +164% | +$469K | ﹤0.01% | 2664 |
|
|
2017
Q2 | $296K | Sell |
7,500
-12,600
| -63% | -$460K | ﹤0.01% | 3608 |
|
|
2017
Q1 | $630K | Sell |
20,100
-6,900
| -26% | -$216K | ﹤0.01% | 2618 |
|
|
2016
Q4 | $843K | Buy |
+27,000
| New | +$875K | ﹤0.01% | 2273 |
|
|
2016
Q3 | – | Sell |
-13,800
| Closed | -$459K | – | 4124 |
|
|
2016
Q2 | $459K | Sell |
13,800
-37,800
| -73% | -$1.29M | ﹤0.01% | 2857 |
|
|
2016
Q1 | $1.52M | Buy |
51,600
+38,700
| +300% | +$1.07M | 0.01% | 1440 |
|
|
2015
Q4 | $340K | Buy |
12,900
+1,500
| +13% | +$39K | ﹤0.01% | 2938 |
|
|
2015
Q3 | $270K | Sell |
11,400
-13,200
| -54% | -$319K | ﹤0.01% | 2897 |
|
|
2015
Q2 | $584K | Buy |
+24,600
| New | +$555K | ﹤0.01% | 2128 |
|
Other funds holding EW
VCM
VPM
Jane Street's EW Position: Q1 2026 in Review
Jane Street reduced its Edwards Lifesciences (EW) stake by 34% in Q1 2026, selling an estimated $16.6M and leaving 390,333 shares worth $31.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1407.
Jane Street first reported a position in EW in Q1 2014 and has held it in 45 quarters since. The position peaked at $121M in Q3 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Jane Street held 390,333 shares of Edwards Lifesciences worth $31.3M as of Q1 2026.
- Jane Street sold 201,167 Edwards Lifesciences shares in Q1 2026, an estimated $16.6M.
- Edwards Lifesciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1407 holding.
- Jane Street first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 45 quarters since.
- Jane Street's Edwards Lifesciences position peaked at $121M in Q3 2025.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.